Annandale Capital, LLC

Position in RNTX — Rein Therapeutics, Inc.

CIK 1811739 DALLAS, TX

Position in RNTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$15,627

-$3,906 QoQ

Shares Held

15,026

0.0% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#48

of 59 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Annandale Capital, LLC holds $1,728,367 across 3 Biotechnology names. RNTX ranks #3 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	URGN	UroGen Pharma Ltd.	45,425	$1,671,640
2	IRD	Opus Genetics, Inc.	10,000	$41,100
3	RNTX	Rein Therapeutics, Inc. This page	15,026	$15,627

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,627	15,026	0.0%	Shares	Sole	2026-08-13
2026-03-31	$19,533	15,026	0.0%	Shares	Sole	2026-05-15
2025-12-31	$17,430	15,026	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.